REHOVOT, Israel and JERSEY CITY, New Jersey, October 27 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, today announced that Credit Suisse, as part of a settlement agreement it has reached with the Attorney General of the State of New York and the North American Securities Administrators Association Task Force, has begun to repurchase Rosetta Genomics ARS. So far, Credit Suisse has repurchased $2.7M worth of the $7.5M in ARS held by Rosetta Genomics.

BATON ROUGE, Louisiana, October 27 /PRNewswire/ --

- Breakthrough Activation Technology Doubles Catalyst Activity without Modifying Target Resin Properties

Albemarle Corporation (NYSE: ALB) a global leader in supported single-site catalyst production and metallocene catalyst components, has created a revolutionary new activator/single-site catalyst program that delivers twice the typical productivity of conventional products.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )

Viruses are nasty opponents, as anyone who has followed the battles against influenza, SARs and HIV/AIDS can attest. They are diverse and in many cases evolve at rates that confound efforts to contain them. Anyone who has gotten a flu shot, and then came down with the flu a few months later because the “strain” of virus that the vaccine was not the same as the “strain” that they were infected with, knows just how fast viruses can evolve. In many cases, medical professional never really know which virus has caused the symptoms in their patients, and this complicates treatment and often leads to the misuse of antibiotics, which, of course, are never effective against viruses.

Since their discovery, stem cells have been hailed as the ultimate answer for crippling and incurable diseases such as Alzheimer’s, Parkinson’s and other conditions that leave vital organs like heart or nerves damaged beyond repair. Researchers from the University of Cambridge, under the leadership of Professor Austin Smith, Director of the Wellcome Trust Centre for Stem Cell Research at the University of Cambridge, recently published a paper(1) detailing a new technology that can transform adult stem cells into induced pluripotent stem cells (iPS). This technique is able to reliably reprogram adult cells into iPS rapidly and can forego the need to rely on mammalian embryos to generate pluripotent stem cells.

ANTONY, France, October 27 /PRNewswire/ -- Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R) Grasses in the treatment of allergic rhinoconjunctivitis to grass pollens in adults.

The aim of the study, which will be conducted in 450 American patients during the 2009 pollen season, is to confirm the efficacy and good tolerance of the product in adults and to support the application for authorization to market it in the United States.

WASHINGTON, October 27 /PRNewswire/ --

- Data presented at the joint annual meeting of ICAAC and IDSA

- Results suggest candidate vaccine may be as effective as Prevnar for the seven shared serotypes, and provide expanded coverage for six additional serotypes

- Wyeth on track to complete U.S. filing for pediatric use in the first quarter of 2009, with other pediatric global filings expected at the same time, or possibly earlier

LONDON, October 27 /PRNewswire/ --

- Unite Photo Opportunity:

LOCATION: Old Palace Yard/College Green, Westminster, SW1A. DATE: Tuesday 28th October, 2008. TIME: from 1.00pm.

Hundreds of union members will descend on Westminster tomorrow (Tuesday, 28th) to lobby Parliament to demand justice for asbestos victims and the restoration of compensation for victims of pleural plaques.

Unite believe thousands of seriously wronged workers have been plunged into compensation limbo by the House of Lords decision, in October 2007, which ended the right of asbestos victims suffering from this disease to compensation.

RIYADH, Saudi Arabia, October 27 /PRNewswire/ -- Saudi Research and Marketing Group (SRMG), the largest integrated publishing group in the Middle East, announced the establishment of a joint venture with Saudi Arabia's leading telecommunications company, Saudi Telecom (STC) and ALL ASIA NETWORKS plc (ASTRO), a leading cross-media operator with operations in Malaysia, Brunei, Indonesia and India.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081027/325985 )

This new Content Joint Venture (CJV), which will be based in Dubai, creates the first Content Aggregator in the Middle East and North Africa Region.

CHARLOTTESVILLE, Virginia, October 27 /PRNewswire/ --

A Canadian Navy destroyer just completed the first successful sea trials with a new-generation inertial navigation system (INS) and data distribution network supplied by Northrop Grumman Corporation (NYSE: NOC).

The Iroquois-class destroyer, HMCS Athabaskan, is the first naval ship to go to sea with the MK49 ring-laser gyro navigator (RLGN) INS and Navigation Data Distribution System (NavDDS). The systems were developed by Northrop Grumman's Sperry Marine business unit.

AMSTERDAM, Netherlands and NEW YORK, October 27 /PRNewswire/ --

Game Publisher Playlogic Entertainment, Inc. (OTC Bulletin Board: PLGC) today announces that its in-house studio, Playlogic Game Factory, continues its collaboration with SCEE London Studio's First Party development team, part of Sony Computer Entertainment Europe Limited (SCEE).

Playlogic Game Factory recently completed the development on EyeToy(R) Pom Pom Party(c) for the PlayStation(R)2 which will be released this quarter.

Furthermore, the Playlogic Game Factory has been assisting SCEE London Studio with the development of the recently announced EyePet(TM). The collaboration on the development of this project will continue into 2009.